Genetic markers and cancer epidemiology

The study of potential associations between genetic markers and various cancers has a long history in cancer epidemiology. Such investigations are subject to serious problems of statistical significance and the choice of appropriate control populations. A promising future for the use of human population genetics in cancer epidemiology may be in the investigation of genetic markers (such as the HL‐A complex) which code for proteins of potential immunological or physiological importance in susceptibility or resistance to cancer. The cerumen genetic marker has played a central part in a hypothesis formulated in our laboratory for the etiology of breast cancer. A second new development in this field is likely to be the investigation of genetic markers in families with high incidence of cancer. Such families permit the simultaneous study of genetic hypotheses of cancer inheritance and the association of marker genotypes with cancer through segregation and linkage analysis.

[1]  A. Munro,et al.  Products of the major histocompatibility complex and their relationship to the immune response , 1976, Nature.

[2]  F. Ruddle,et al.  Parasexual approaches to the genetics of man. , 1975, Annual review of genetics.

[3]  H. Lynch,et al.  Hl‐a in cancer family “n” , 1975, Cancer.

[4]  N. Petrakis,et al.  Association of race, age, menopausal status, and cerumen type with breast fluid secretion in nonlactating women, as determined by nepple aspiration. , 1975, Journal of the National Cancer Institute.

[5]  J. Dausset,et al.  Some Contributions of the HL‐A Complex to the Genetics of Human Diseases , 1975, Transplantation reviews.

[6]  M. Nei,et al.  Genic variation within and between the three major races of man, Caucasoids, Negroids, and Mongoloids. , 1974, American journal of human genetics.

[7]  H. Mcdevitt,et al.  HL-A, immune-response genes, and disease. , 1974, Lancet.

[8]  P. Buell.  Changing incidence of breast cancer in Japanese-American women. , 1973, Journal of the National Cancer Institute.

[9]  D. James,et al.  HL-A and carcinoma of the breast. , 1973, Lancet.

[10]  W. Bodmer.  Genetic factors in Hodgkin's disease: association with a disease-susceptibility locus (DSA) in the HL-A region. , 1973, National Cancer Institute monograph.

[11]  P. Perlmann,et al.  Carcinoembryonic antigen and blood group substances. , 1973, Cancer research.

[12]  H. Ho,et al.  Evidence against association between wet cerumen and breast cancer. , 1973, Lancet.

[13]  M. Habal,et al.  Histocompatibility (HL-A) antigens and cancer of the breast. Association with antigen HL-A7. , 1972, American journal of surgery.

[14]  M. Vessey,et al.  Breast cancer and the S blood-group system. , 1972, Lancet.

[15]  D. Anderson,et al.  Some characteristics of familial breast cancer , 1971, Cancer.

[16]  N. Petrakis.  Cerumen Genetics and Human Breast Cancer , 1971, Science.

[17]  Wiener As.  Controversy in human genetics. Blood groups and disease. , 1970 .

[18]  F. Vogel.  Controversy in human genetics. ABO blood groups and disease. , 1970, American journal of human genetics.

[19]  D. Shreffler,et al.  Effects of secretor, blood, and serum groups on isoantibody and immunoglobulin levels. , 1970, American journal of human genetics.

[20]  N. Petrakis.  Dry Cerumen—a Prevalent Genetic Trait among American Indians , 1969, Nature.

[21]  A. Jandová,et al.  Serum haptoglobin type in females with genital cancer. , 1969, Journal of the National Cancer Institute.

[22]  N. Hughes.  Gc group distributions in patients with cancer. , 1968, Journal of the National Cancer Institute.

[23]  M. Larkin.  Serum haptoglobin type and cancer. , 1967, Journal of the National Cancer Institute.

[24]  A. Peacock.  Serum haptoglobin type and leukemia: an association with possible etiological significance. , 1966, Journal of the National Cancer Institute.

[25]  R. Shirley,et al.  Association of Leukaemia and Blood Groups , 1965 .

[26]  G. Springer,et al.  BLOOD GROUP ACTIVITY OF GRAM-NEGATIVE BACTERIA , 1961, The Journal of experimental medicine.

[27]  A. Manuila.  Blood groups and disease-hard facts and delusions. , 1958, Journal of the American Medical Association.

[28]  J. Buckwalter,et al.  ABO blood groups and disease. , 1956, Journal of the American Medical Association.

[29]  B. Billington.  Gastric cancer; relationships between ABO blood-groups, site, and epidemiology. , 1956, Lancet.

[30]  T. Allan.  Blood Groups and Disease , 1955 .

[31]  B. Woolf.  ON ESTIMATING THE RELATION BETWEEN BLOOD GROUP AND DISEASE , 1955, Annals of human genetics.

[32]  H. Bentall,et al.  Relationship Between Cancer of Stomach and the ABO Blood Groups , 1953, British medical journal.

[33]  Alexander.  An Inquiry into the Distribution of the Blood Groups in Patients Suffering from ???Malignant Disease.??? , 1921 .

[34]  R. Elston,et al.  General models for segregation analysis. , 1975, American journal of human genetics.

[35]  G. Dahlberg,et al.  Genetics of human populations. , 1948, Advances in genetics.